A method for constructing porcine BECN1 gene knockout cells and its application
The CRISPR/Cas9 system is used to construct porcine BECN1 gene knockout cells, effectively inactivating BECN1 protein expression for research on autophagy and viral infection, offering a high-efficiency, low-cost tool for studying BECN1 gene function.
Patent Information
- Application Number
- CN202410675517.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-29
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-05-29
AI Technical Summary
Current methods lack an efficient and cost-effective means to construct and utilize porcine BECN1 gene knockout cells for studying the role of BECN1 in autophagy and viral infection processes.
A method using the CRISPR/Cas9 system to construct porcine BECN1 gene knockout cells by designing specific guide RNA (sgRNA) sequences, annealing, and transfecting them into PPE cells with puromycin screening to achieve targeted gene knockout.
The method successfully inactivates BECN1 protein expression, enabling stable inheritance and providing a valuable tool for studying BECN1 gene function and related pathways with high efficiency and low cost.
Smart Images

Figure CN118581151B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of genetic engineering, and in particular to a method for constructing a pig BECN1 gene knockout cell and an application thereof. Background Art
[0002] Autophagy is the process of degradation of intracellular entities through lysosomes. Since autophagy has the function of protein and organelle turnover, its execution depends on a large molecular network that can work together to maintain the balance of the cell. Autophagy induced under environmental challenges such as hypoxia or starvation is also an adaptive response that helps cells survive under these conditions by using decomposition products in other metabolic pathways. Autophagosomes are double-membrane vesicles that encapsulate degradation targets and fuse with lysosomes, playing a key role in the biogenesis of autophagosomes. There are three main targeting pathways in the process of cellular autophagy: mTOR (mammalian target ofrapamycin), BECN1 and LC3. As a cell signaling protein, mTOR regulates cell growth, division and metabolism, and can also inhibit autophagy; BECN1 is an essential basic factor in the process of autophagosome formation, and the role of cellular autophagy can only be achieved when and only when BECN1 is activated; LC3 is mainly involved in the targeting components of autophagosomes and autophagic membranes, and participates in the decomposition of autophagosomes.
[0003] The BECN1 gene, also known as Beclin1, is a member of the autophagy-related protein family and is involved in regulating the formation of autophagic vesicles. It promotes the maturation of autophagic vesicles by interacting with multiple proteins, such as Vps34 and UVRAG. BECN1 is essential for the autophagy process. It is involved in regulating the cell's response to nutrient deprivation and maintaining cellular homeostasis during cellular stress responses. Through the autophagy process, BECN1 helps cells break down and recycle long-lived proteins and damaged organelles in the cell.
[0004] BECN1 exerts its autophagic and membrane trafficking functions by interacting with several other proteins, including vacuolar protein sorting-associated protein 15 (VPS15), VPS34, ultraviolet radiation resistance-associated gene product (UVRAG), and autophagy-related protein 14 (ATG14). Depending on the presence of ATG14 or UVRAG, these complexes assemble into two distinct class III PI3K complexes, complex 1 (C1) and complex 2 (C2). In these complexes, the catalytic lipid kinase subunit VSP34 is responsible for the phosphorylation of PtdIns, which then mediates autophagic and / or membrane trafficking functions by recruiting effector proteins. BECN1 is a scaffold protein for both complexes, acting as a signal integration hub for different cellular pathways and ectopically regulating the lipid kinase activity of VPS34.
[0005] As mentioned above, BECN1 is a scaffold in the PI3K class III C1 and C2 complexes that ectopically regulates the activity of their associated lipid kinases. Both complexes consist of three core proteins, VPS34, VPS15, and BECN1, but differ in their fourth core subunit and fifth subunit / accessory protein.
[0006] In C1, the unique fourth core subunit is ATG14, and nuclear receptor binding factor 2 (NRBF2) is sometimes included as a fifth accessory protein. The C1 complex is primarily involved in autophagy, particularly nucleation of the autophagosome double membrane. In C2, the unique fourth core subunit is UVRAG, and two additional subcomplexes formed by the binding of RUBICON or BAX interacting factor 1 (BIF-1 / Endophilin B1) serve as fifth accessory proteins. In contrast to C1, C2 also plays a role in endocytic trafficking and lysosomal tubulation in addition to autophagy.
[0007] In summary, BECN1, as an important member of the class III PI3K complex, plays a key role in regulating autophagy and other membrane transport processes. Without BECN1, the stability of other members of these complexes (ATG14 and UVRAG) is affected. Protein-protein interactions, phosphorylation, ubiquitination, cleavage, and other events triggered by various cellular pathways on BECN1 affect the ability of BECN1 to play a signal integration scaffold role in these complexes, making BECN1 an important site for the crosstalk between autophagy, apoptosis, and cell proliferation.
[0008] Studies have shown that autophagy also plays an important role in the process of viral infection. In the early stage of infection, the virus will promote the inhibition of the mTOR pathway, thereby triggering the initiation of cellular autophagy. When cellular autophagy is activated, a large number of cellular components will be encapsulated in the autophagosome and combined with the viral structure and components to form an autophagosome. In the next step, the autophagosome combines with the lysosome, the viral particles in the autophagosome are dissolved, and finally inactivated by the acidic environment, thereby preventing the further spread of the virus in the cell. In the late stage of infection, the retention and accumulation of viral particles can lead to the formation of polypeptide antigens, thereby initiating a natural immune response against the virus. This response includes antibodies, cytotoxicity, and T cell stimulation, which can further resist viral infection and spread. In addition, a large number of studies have shown that many viruses also use cellular autophagy to promote their own replication and spread, including viruses such as foot-and-mouth disease and African swine fever.
[0009] The role and mechanism of cellular autophagy in viral infection has become a research hotspot. The method of constructing BECN1 gene knockout cell line based on CRISPR / Cas9 system will provide a feasible tool for autophagy research. Summary of the invention
[0010] In order to solve the above problems, the present invention provides a method for constructing a porcine BECN1 gene knockout cell and its application. The construction method provided by the present invention can achieve the knockout of the porcine BECN1 gene.
[0011] In order to achieve the above object, the present invention provides the following technical solutions:
[0012] The present invention provides a method for constructing a porcine BECN1 gene knockout cell, comprising the following steps:
[0013] 1) Add the sticky ends of Bbs1 restriction endonuclease and adapter to the sgRNA to obtain the insert fragment;
[0014] The nucleotide sequence of the sgRNA is shown in SEQ ID No. 1;
[0015] 2) annealing the inserted fragment obtained in step 1) and its complementary sequence to obtain a double-stranded fragment;
[0016] The nucleotide sequence of the complementary sequence is shown in SEQ ID No.2;
[0017] 3) connecting the double-stranded fragment obtained in step 2) with the PX459 vector, transforming the obtained ligation product into competent Escherichia coli, extracting the plasmid, and obtaining the recombinant plasmid PX459M-BECN1-sgRNA;
[0018] The PX459 vector was digested with Bbs1 enzyme;
[0019] 4) mixing the recombinant plasmid PX459M-BECN1-sgRNA obtained in step 3) with Lip2000 liposomes and PPE cells, and transfecting the mixture to obtain transfected cells;
[0020] 5) The transfected cells obtained in step 4) are subjected to puromycin screening for positive single cell clones to obtain a PPE cell line with porcine BECN1 gene knockout.
[0021] Preferably, the linker in step 1) is CACCG, and the nucleotide sequence of the inserted fragment is shown in SEQ ID No.2.
[0022] Preferably, the annealing system in step 2) is: 13.5 μL of the insert fragment with a concentration of 10 μM, 13.5 μL of the complementary sequence with a concentration of 10 μM, and 3 μL of 10×PCRBuffer;
[0023] The annealing conditions are: annealing at 99° C. for 5 minutes.
[0024] Preferably, the enzyme digestion system in step 3) is: 2 μg of PX459 vector, 2 μL of Bbs1 enzyme, 5 μL of 10×buffer G, and ddH2O is added to make up the system to 50 μL; the enzyme digestion conditions are: reacting in a 37° C. water bath for 2 to 4 hours.
[0025] Preferably, the system for connection in step 3) is: 50 ng of PX459 vector, 0.5 μL of 10×T4 buffer, 2 μL of double-stranded fragment, 0.5 μL of T4 DNAligase, and ddH2O is added to make up the system to 5 μL;
[0026] The connection conditions are: reaction at 16°C for 1 hour.
[0027] Preferably, in step 4), the ratio of the mass of the recombinant plasmid PX459M-BECN1-sgRNA to the volume of Lip2000 liposomes and the number of PPE cells is 1 μg: 2 μL: 1×10 6 indivual.
[0028] Preferably, the transfection time in step 4) is 24 hours.
[0029] Preferably, the concentration of puromycin used in step 5) is 1.5-2.5 μg / mL.
[0030] Preferably, the puromycin is mixed with a complete culture medium before screening, and the medium is changed every 2 days.
[0031] The present invention also provides application of the construction method described in the above technical solution in obtaining a porcine BECN1 gene knockout PPE cell line.
[0032] The beneficial effects of the present invention are:
[0033] 1. The present invention successfully constructed a BECN1 gene knockout PPE cell line in which BECN1 protein expression was inactivated due to the deletion of BECN1 gene fragment.
[0034] 2. The present invention utilizes the CRISPR-Cas9 system, and through gene sequencing identification and protein immunoblotting verification, it is determined that a BECN1 gene knockout PPE cell line was successfully constructed.
[0035] 3. The BECN1 gene knockout constructed by the present invention can be stably inherited to daughter cells along with cell proliferation and division.
[0036] 4. The PX459-BECN1-sgRNA plasmid constructed by the present invention has puromycin resistance. Adding puromycin to screen positive cells is beneficial to improving the positive rate of obtaining BECN1 gene knockout monoclonal cell lines.
[0037] 5. The present invention can be used for targeted knockout of the BECN1 gene, and has the characteristics of simplicity, high efficiency, rapidity, and low cost, and is of great significance for the study of the function of the BECN1 gene and related pathways. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required to be used in the embodiments are briefly introduced below.
[0039] Figure 1 It is the sequencing comparison result of the BECN1 gene of the single cell clone after the PX459-BECN1-sgRNA plasmid of the present invention was transfected into PPE cells;
[0040] Figure 2 It is the Western-Blotting detection result of BECN1 protein expression in a single cell clone after the PX459-BECN1-sgRNA plasmid of the present invention was transfected into PPE cells;
[0041] Figure 3 This is a microscopic image of a single-cell clone of PPE cells after BECN1 gene knockout of the present invention. DETAILED DESCRIPTION
[0042] The present invention provides a method for constructing a porcine BECN1 gene knockout cell, comprising the following steps:
[0043] 1) Add the sticky ends of Bbs1 restriction endonuclease and adapter to the sgRNA to obtain the insert fragment;
[0044] The nucleotide sequence of the sgRNA is shown in SEQ ID No. 1;
[0045] 2) annealing the inserted fragment obtained in step 1) and its complementary sequence to obtain a double-stranded fragment;
[0046] The nucleotide sequence of the complementary sequence is shown in SEQ ID No.2;
[0047] 3) connecting the double-stranded fragment obtained in step 2) with the PX459 vector, transforming the obtained ligation product into competent Escherichia coli, extracting the plasmid, and obtaining the recombinant plasmid PX459M-BECN1-sgRNA;
[0048] The PX459 vector was digested with Bbs1 enzyme;
[0049] 4) mixing the recombinant plasmid PX459M-BECN1-sgRNA obtained in step 3) with Lip2000 liposomes and PPE cells, and transfecting the mixture to obtain transfected cells;
[0050] 5) The transfected cells obtained in step 4) are subjected to puromycin screening for positive monoclonal cell strains to obtain a PPE cell line with porcine BECN1 gene knockout.
[0051] In the present invention, the sticky end and linker of the Bbs1 restriction endonuclease are added to the sgRNA to obtain an insert fragment; the nucleotide sequence of the sgRNA is shown in SEQ ID No. 1, which is as follows:
[0052] CCTGAATGGTAACACGATCC.
[0053] In the present invention, the linker is preferably CACCG, and the nucleotide sequence of the insert is shown in SEQ ID No. 3, specifically as follows:
[0054] 5'-CACCGCCTGAATGGTAACACGATCC-3'.
[0055] The present invention anneals the obtained insert fragment and its complementary sequence to obtain a double-stranded fragment; the nucleotide sequence of the complementary sequence is shown in SEQ ID No.4, which is as follows:
[0056] 5'-AAACGGATCGTGTTACCATTCAGGC-3'.
[0057] In the present invention, the annealing system is preferably: 13.5 μL of an insert fragment with a concentration of 10 μM, 13.5 μL of a complementary sequence with a concentration of 10 μM, and 3 μL of 10×PCR Buffer. In the present invention, the annealing conditions are preferably: annealing at 99° C. for 5 min.
[0058] In the present invention, the obtained double-stranded fragment is connected to the PX459 vector, the obtained connection product is transformed into competent Escherichia coli, and the plasmid is extracted to obtain the recombinant plasmid PX459-BECN1-sgRNA; the PX459 vector is digested with Bbs1 enzyme.
[0059] In the present invention, the enzyme digestion system is preferably: PX459 vector 2μg, Bbs1 enzyme 2μL, 10×buffer G 5μL, add ddH2O to make up the system to 50μL. In the present invention, the enzyme digestion conditions are preferably: react in a 37°C water bath for 2 to 4h. In the present invention, the ligation system is preferably: PX459 vector 50ng, 10×T4 buffer 0.5μL, double-stranded fragment 2μL, T4 DNAligase 0.5μL, add ddH2O to make up the system to 5μL. In the present invention, the ligation conditions are preferably: react at 16°C for 1h.
[0060] In the present invention, the obtained recombinant plasmid PX459M-BECN1-sgRNA is mixed with Lip2000 liposomes and PPE cells, and then transfected to obtain transfected cells.
[0061] In the present invention, the mass of the recombinant plasmid PX459M-BECN1-sgRNA, the volume of Lip2000 liposomes, and the number of PPE cells are preferably 1 μg: 2 μL: 1×10 6 In the present invention, the transfection time is preferably 24h.
[0062] The present invention uses puromycin to screen positive monoclonal cell lines of the obtained transfected cells to obtain a PPE cell line with porcine BECN1 gene knockout. In the present invention, the concentration of the puromycin used is preferably 1.5 to 2.5 μg / mL. The present invention preferably mixes the puromycin with a complete culture medium for screening, and changes the medium once every 2 days.
[0063] The present invention also provides application of the construction method described in the above technical solution in obtaining a porcine BECN1 gene knockout PPE cell line.
[0064] In order to further illustrate the present invention, the present invention is described in detail below in conjunction with embodiments, but they should not be construed as limiting the scope of protection of the present invention.
[0065] Example 1
[0066] Vector construction
[0067] 1). Design of sgRNA for BECN1 gene
[0068] The porcine BECN1 genome sequence was obtained by searching the Genebank website for the BECN1 gene (gene name: BECN1, gene ID number: 7733576, for detailed gene information, see https: / / www.ncbi.nlm.nih.gov / gene / 733576).
[0069] In the mRNA introduction, select the mRNA with the most complete fragments (see mRNA information for details). https: / / www.ncbi.nlm.nih.gov / nuccore / XM_013980932.2 ), find and download the gene coding region sequence.
[0070] sgRNA was designed using online software (http: / / crispor.tefor.net / ), the above gene coding region sequence was input, several sgRNA sequences were set and retrieved, and the position of sgRNA on the gene sequence and the off-target information of the sgRNA were analyzed to select an optimal sgRNA sequence, as shown in Seq-1, as shown in Table 1:
[0071] Table 1 Target sequences
[0072] Serial Number name Target sequence SEQ ID No.1 Seq-1 CCTGAATGGTAACACGATCC SEQ ID No.2 Seq-2 GGATCGTGTTACCATTCAGG SEQ ID No.3 Seq-3 CACCGCCTGAATGGTAACACGATCC SEQ ID No.4 Seq-4 AAACGGATCGTGTTACCATTCAGGC
[0073] 2) Synthesize sgRNA double-stranded fragments and anneal
[0074] The sgRNA designed above is to be cloned into the PX459 vector. The sgRNA sequence is added with the sticky end of the Bbs1 restriction endonuclease and sent to the bioengineering biosynthetic single nucleotide chain.
[0075] Add a linker to the Seq-1 sequence to synthesize the insert fragment BECN1-sgRNA:
[0076] Seq-1F: 5'-CACCGCCTGAATGGTAACACGATCC (SEQ ID No. 3)
[0077] Seq-1R: 5'-AAACGGATCGTGTTACCATTCAGGC (SEQ ID No. 4);
[0078] Seq-F and Seq-R were mixed in equal volumes for annealing reaction. The annealing reaction system included 13.5 μL of each primer shown in Seq-F and Seq-R at a concentration of 10 μM and 3 μL of 10×PCRBuffer. The mixture was placed in a PCR instrument for reaction at 99°C for 5 min and 4°C for ∞. The double-stranded fragment of sgRNA was obtained, which could be connected to the restriction vector or stored at -20°C for later use.
[0079] 3) Enzyme digestion and gel recovery of PX459 vector
[0080] Take 2μg of PX459 vector and digest it with Bbs1. The digestion system is: PX459 2μg, Bbs1 2μL, 10× buffer G 5μL, add ddH2O to make up the system to 50μL. Mix well and react in a 37℃ water bath for 2-4 hours. Use agarose DNA recovery kit to recover and purify the above digestion products. For specific experimental steps, see the instructions of the agarose DNA recovery kit.
[0081] 4) Ligation of BECN1-sgRNA double-stranded fragment and PX459 vector
[0082] In a 1.5mL EP tube, add 50ng of the PX459 vector after enzyme digestion, 0.5μL of 10×T4 buffer, 2μL of the BECN1-sgRNA double-stranded fragment, and 0.5μL of T4 DNA ligase. Add ddH2O to make up the system to 5μL. Mix well and react in a ligator at 16℃ for 1h. Store at 4℃ for later use.
[0083] 5) Ligation product transformation and PCR identification
[0084] Add the above ligation product to 50uL competent bacteria and place on ice for 30min; heat shock in a 42℃ water bath for 90s and place on ice for 3min; add 1ml of LB medium without resistance and place in a 37℃ shaker to recover and culture for half an hour; centrifuge the bacterial solution at 3000rpm for 20s, discard the supernatant, and resuspend and mix the remaining 100ul liquid; spread the bacterial solution on an ampicillin-resistant plate and place in a 37℃ constant temperature incubator for overnight culture; pick a single colony for expansion culture, extract the recombinant plasmid after harvesting the bacterial solution, and then perform sequencing identification, and save the correctly identified recombinant plasmid PX459M-BECN1-sgRNA.
[0085] Example 2
[0086] Preparation of BECN1 knockout PPE cell line
[0087] 1. PX459M-BECN1-sgRNA transfection into PPE cells
[0088] 1) Cells were inoculated into 12-well plates. PPE cell suspension (from Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences) was taken and the suspension was adjusted to 1×10 6 Inoculate 100 cells / well and evenly spread them into one well of a 12-well plate. Add complete culture medium (containing 5% fetal bovine serum and 1% penicillin-streptomycin double antibody) to 1 mL and place in a cell culture incubator for 12-16 hours.
[0089] 2) Take out two sterile EP tubes and add 100 μL Opti-DMEM culture medium to each of them. Add 1 μg of PX459M-BECN1-sgRNA recombinant plasmid to the first sterile EP tube, which is called liquid A. Add 2 μL Lip2000 liposomes to the second sterile EP tube and mix well, which is called liquid B.
[0090] 3) Gently add liquid B to liquid A, mix evenly (blowing 3-5 times with a gun), and let stand at room temperature for 25 minutes;
[0091] 4) Gently add the A / B mixture dropwise into the corresponding 12-well plate, gently shake the cell culture plate back and forth, and then return the 12-well plate to the cell culture incubator for further culturing for 24 hours.
[0092] 2. Puromycin drug screening
[0093] 1) 24 hours after transfection, the cells were digested with trypsin and divided into three parts. 1 mL of culture medium with different final concentrations of puromycin (final concentrations of 1.5 ug / mL, 2 ug / mL, and 2.5 ug / mL) was added to each part and mixed by pipetting. Each concentration of cells was matched with a wild-type cell (WT cell) that was not transfected as a control.
[0094] 2) Change the medium every two days, and use WT cells as the control. If all cells in the control group die at a certain puro final concentration, but cells in the experimental group do not die completely, select the experimental group with this puro final concentration for the next step.
[0095] 3) The culture medium of the experimental group is replaced, generally with 10% complete culture medium, and the culture is continued for 3-4 days. After the transfected cells recover and grow a small amount, the next step is performed.
[0096] 3. Target gene targeting detection
[0097] 1) Digest the selected cells with trypsin and collect 50% of the cells;
[0098] 2) Extract the genome of the cells using a genome extraction kit;
[0099] 3) Using the extracted cell genomic DNA as a template, perform PCR amplification with the following primers:
[0100] seq-F(SEQ ID No.5):GAAGGGACTTTTCTAGGCTCAGG;
[0101] seq-R(SEQ ID No.6):CCCTCCTTGTCTTTGGGTCGTAA;
[0102] The PCR reaction system included 25 μL of 2×Taq Master Mix, 2 μL of each primer shown in Seq-F and Seq-R at a concentration of 10 μM, 0.1 μg of template DNA, and ddH2O to make up the system to 50 μL; the PCR reaction program was 95°C pre-denaturation reaction for 3 min; 95°C denaturation reaction for 15 s, 60°C annealing reaction for 15 s, 72°C extension reaction for 45 s, 35 cycles; 72°C extension for another 5 min;
[0103] 4) Perform agarose gel electrophoresis on the amplified product to observe the band size of the amplified product (about 500 bp), and sequence the PCR product for identification.
[0104] 4. Cell monoclonal culture
[0105] 1) Take 400 cells after screening in step 1) of step 3, add them into 20 mL of complete culture medium, and mix by pipetting;
[0106] 2) The cell suspension was plated into two 96-well culture plates using a spray gun, 100 μL / well;
[0107] 3) After culturing the cells for 4 hours, observe the cell growth under a microscope and mark the single cell clones.
[0108] 5. Single-cell clone gene level verification
[0109] 1) When the density of single-cell clones grows to 50%-60% of the area at the bottom of the well, use trypsin to digest the cells, take out 50% of the cells into an EP tube, extract the cell genome for gene sequencing verification, and continue to culture and amplify the remaining 50% of the cells in a 24-well plate;
[0110] 2) Using the extracted cell genomic DNA as a template, perform PCR amplification with the following primers:
[0111] seq-F:GAAGGGACTTTTCTAGGCTCAGG;
[0112] seq-R:CCCTCCTTGTCTTTGGGTCGTAA;
[0113] The PCR reaction system included 25 μL of 2×Taq Master Mix, 2 μL of each of the primers Seq-F and Seq-R at a concentration of 10 μM, 0.1 μg of template DNA, and ddH2O to make up the system to 50 μL. The PCR reaction program was 95°C pre-denaturation reaction for 3 min; 95°C denaturation reaction for 15 s, 60°C annealing reaction for 15 s, 72°C extension reaction for 45 s, 35 cycles; 72°C extension for 5 min.
[0114] 4) The amplified products were detected by agarose gel electrophoresis, the band sizes of the amplified products were observed, the amplified products were sequenced and identified, and after the positive cells were confirmed by sequencing comparison, the positive cells were expanded and cultured, and cryopreserved, named PPE-BECN1-KO, and the sequencing result comparison chart.
[0115] 6. Western Blot detection of BECN1 protein expression in monoclonal cell lines
[0116] In order to verify the knockout effect of the BECN1 gene, we used Western Blot experiments to detect the expression of BECN1 protein in the BECN1 gene knockout PPE cell line.
[0117] 1) Cell collection: PPE-BECN1-KO single cell clones and normal PPE cells were digested with trypsin, collected into 1.5 mL centrifuge tubes, centrifuged and discarded the supernatant, retaining the cell pellet;
[0118] 2) Lyse cells: Add NP-40 containing protease and phosphatase inhibitors to lyse cells, lyse on ice for 10 minutes, centrifuge at 13000r / min for 15 minutes, take the supernatant into a new 1.5mL centrifuge tube, and measure the protein concentration;
[0119] 3) Sample preparation: Mix the total cell protein supernatant with 5× SDS protein loading buffer at a ratio of 4:1 and boil at 95°C for 5 min;
[0120] 4) Electrophoresis: Prepare 12% SDS-PAGE gel and perform electrophoretic separation of proteins. When concentrating the gel, the voltage is 80V and the time is 30 minutes. When separating the gel, the voltage is 120V and the time is 1 hour.
[0121] 5) Transfer: Wet transfer method, constant voltage 100V, transfer for 1.5 hours;
[0122] 6) Blocking: Use TBST solution with a final concentration of 5% skim milk powder and incubate the membrane at room temperature for 2 hours;
[0123] 7) Primary antibody incubation: dilute the primary antibody BECN1 mAb (CST) at a dilution of 1:2000 in a TBST solution with a final concentration of 5% skim milk powder and incubate at 4°C overnight;
[0124] 8) Secondary antibody incubation: Wash the membrane three times with TBST, 10 minutes each time; dilute Peroxidase-AffiniPureDonkeyAnti-Goat IgG (H+L) (Jackson: 705-035-147) 1:5000 in a TBST solution with a final concentration of 5% skim milk powder, and incubate at room temperature for 1 hour.
[0125] 9) Exposure imaging: Wash the membrane three times with TBST, 10 minutes each time. Take equal amounts of chemiluminescent HRP (ECLWBKLS0500) colorimetric solution A and solution B, mix them evenly, and use a gel imaging instrument to image.
[0126] The results showed that BECN1 protein signals existed in PPE wild cells, while no BECN1 protein signals were detected in PPE-BECN1-KO single cell clones, indicating that the single cell clone achieved BECN1 gene knockout at the protein level.
[0127] The present invention utilizes the BECN1 gene knockout PPE cell line constructed by the CRICPR / Cas9 system to edit the BECN1 gene at the DNA level and completely silence the expression of the BECN1 protein, thus providing a practical tool for the study of the BECN1 gene function.
[0128] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.
Claims
1. A method for constructing porcine BECN1 gene knockout cells, characterized in that: The following steps are involved: 1) Add the sticky ends of Bbs1 restriction endonuclease and adapter to the sgRNA to obtain the insert fragment; The nucleotide sequence of the sgRNA is shown in SEQ ID No. 1; The linker is CACCG, and the nucleotide sequence of the inserted fragment is shown in SEQ ID No. 3; 2) annealing the inserted fragment obtained in step 1) and its complementary sequence to obtain a double-stranded fragment; The nucleotide sequence of the complementary sequence is shown in SEQ ID No.4; 3) connecting the double-stranded fragment obtained in step 2) with the PX459 vector, transforming the obtained ligation product into competent Escherichia coli, extracting the plasmid, and obtaining the recombinant plasmid PX459M-BECN1-sgRNA; The PX459 vector was digested with Bbs1 enzyme; 4) mixing the recombinant plasmid PX459M-BECN1-sgRNA obtained in step 3) with Lip2000 liposomes and PPE cells, and transfecting the mixture to obtain transfected cells; The mass of the recombinant plasmid PX459-BECN1-sgRNA, the volume of Lip2000 liposomes, and the number of PPE cells were 1 μg: 2 μL: 1×10 6 indivual; 5) The transfected cells obtained in step 4) are subjected to puromycin screening for positive monoclonal cell strains to obtain a PPE cell line with porcine BECN1 gene knockout.
2. The construction method according to claim 1, characterized in that: The annealing system in step 2) is: 13.5 μL of the inserted fragment with a concentration of 10 μM, 13.5 μL of the complementary sequence with a concentration of 10 μM, and 3 μL of 10×PCR Buffer; the annealing conditions are: annealing at 99° C. for 5 min.
3. The construction method according to claim 1, characterized in that: The enzyme digestion system of step 3) is: 2 μg of PX459 vector, 2 μL of Bbs1 enzyme, 5 μL of 10×buffer G, and ddH2O is added to make up the system to 50 μL; the enzyme digestion conditions are: react in a 37° C. water bath for 2 to 4 hours.
4. The construction method according to claim 1, characterized in that: The ligation system in step 3) is: 50 ng of PX459 vector, 0.5 μL of 10×T4 buffer, 2 μL of double-stranded fragment, 0.5 μL of T4 DNA ligase, and ddH2O is added to make up the system to 5 μL; The connection conditions are: reaction at 16°C for 1 hour.
5. The construction method according to claim 1, characterized in that: The transfection time in step 4) is 24 hours.
6. The construction method according to claim 1, characterized in that: The concentration of puromycin used in step 5) is 1.5-2.5 μg / mL.
7. The construction method according to claim 6, characterized in that: The puromycin was mixed with a complete culture medium for screening, and the puromycin culture medium was replaced once every 2 days.
8. Use of the construction method according to any one of claims 1 to 7 in obtaining a porcine BECN1 gene knockout PPE cell line.
Citation Information
Patent Citations
Use of interfering RNA in production of transgenic animals
CN103397019A
Expression cassette for production of high-expression and high-functionality target protein and use thereof
CN111386348A
